Published March 18, 2020 | Version v1
Journal article Open

Hepato(Geno)Toxicity Assessment of Nanoparticles in a HepG2 Liver Spheroid Model

  • 1. Health Effects Laboratory, Department for Environmental Chemistry, NILU—Norwegian Institute for Air Research, Instituttveien 18, 2007 Kjeller, Norway
  • 2. Institut Català de Nanociència y Nanotecnologia (ICN2-UAB-CSIC-BIST), Campus UAB, Bellaterra, 08193 Barcelona, Spain
  • 3. Fraunhofer Institute for Biomedical Engineering IBMT, Joseph-von-Fraunhofer-Weg 1, 66280 Sulzbach, Germany

Description

Abstract: (1) In compliance with the 3Rs policy to reduce, refine and replace animal experiments, the development of advanced in vitro models is needed for nanotoxicity assessment. Cells cultivated in 3D resemble organ structures better than 2D cultures. This study aims to compare cytotoxic and genotoxic responses induced by titanium dioxide (TiO2), silver (Ag) and zinc oxide (ZnO) nanoparticles (NPs) in 2D monolayer and 3D spheroid cultures of HepG2 human liver cells. (2) NPs were characterized by electron microscopy, dynamic light scattering, laser Doppler anemometry, UV-vis spectroscopy and mass spectrometry. Cytotoxicity was investigated by the alamarBlue assay and confocal microscopy in HepG2 monolayer and spheroid cultures after 24 h of NP exposure. DNA damage (strand breaks and oxidized base lesions) was measured by the comet assay. (3) Ag-NPs were aggregated at 24 h, and a substantial part of the ZnO-NPs was dissolved in culture medium. Ag-NPs induced stronger cytotoxicity in 2D cultures (EC50 3.8 µg/cm2 ) than in 3D cultures (EC50 > 30 µg/cm2 ), and ZnO-NPs induced cytotoxicity to a similar extent in both models (EC50 10.1–16.2 µg/cm2 ). Agand ZnO-NPs showed a concentration-dependent genotoxic effect, but the effect was not statistically significant. TiO2-NPs showed no toxicity (EC50 > 75 µg/cm2 ). (4) This study shows that the HepG2 spheroid model is a promising advanced in vitro model for toxicity assessment of NPs.

Notes

This research was funded by the European Commission under the Horizon2020 program (grant agreement No. 685817, HISENTS, and grant agreement No. 814425, RiskGONE), the hCOMET project (COST Action, CA 15132) and the Norwegian Research Council (272412/F40).

Files

nanomaterials-10-00545 (1).pdf

Files (2.4 MB)

Name Size Download all
md5:0d2aa04c21cf9255a3ad88a6c3ea0d07
2.4 MB Preview Download

Additional details

Funding

HISENTS – High level Integrated SEnsor for NanoToxicity Screening 685817
European Commission
RiskGONE – Risk Governance of Nanotechnology 814425
European Commission